- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 6 x 9UE: Jasplakinolide(Non-covalent)
- 6 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.2: 15 residues within 4Å:- Chain A: G.15, S.16, G.17, M.18, K.20, G.158, D.159, K.215, E.216, G.305, T.306, M.308, Y.309, K.339
- Ligands: MG.3
14 PLIP interactions:14 interactions with chain A- Hydrogen bonds: A:S.16, A:G.17, A:M.18, A:M.18, A:D.159, A:D.159, A:K.215, A:E.216, A:E.216, A:G.305
- Salt bridges: A:K.20, A:K.20, A:K.339
- pi-Stacking: A:Y.309
ADP.5: 15 residues within 4Å:- Chain B: G.15, S.16, G.17, M.18, K.20, G.158, D.159, K.215, E.216, G.305, T.306, M.308, Y.309, K.339
- Ligands: MG.6
14 PLIP interactions:14 interactions with chain B- Hydrogen bonds: B:S.16, B:G.17, B:M.18, B:M.18, B:D.159, B:D.159, B:K.215, B:E.216, B:E.216, B:G.305
- Salt bridges: B:K.20, B:K.20, B:K.339
- pi-Stacking: B:Y.309
ADP.8: 15 residues within 4Å:- Chain C: G.15, S.16, G.17, M.18, K.20, G.158, D.159, K.215, E.216, G.305, T.306, M.308, Y.309, K.339
- Ligands: MG.9
14 PLIP interactions:14 interactions with chain C- Hydrogen bonds: C:S.16, C:G.17, C:M.18, C:M.18, C:D.159, C:D.159, C:K.215, C:E.216, C:E.216, C:G.305
- Salt bridges: C:K.20, C:K.20, C:K.339
- pi-Stacking: C:Y.309
ADP.11: 15 residues within 4Å:- Chain D: G.15, S.16, G.17, M.18, K.20, G.158, D.159, K.215, E.216, G.305, T.306, M.308, Y.309, K.339
- Ligands: MG.12
14 PLIP interactions:14 interactions with chain D- Hydrogen bonds: D:S.16, D:G.17, D:M.18, D:M.18, D:D.159, D:D.159, D:K.215, D:E.216, D:E.216, D:G.305
- Salt bridges: D:K.20, D:K.20, D:K.339
- pi-Stacking: D:Y.309
ADP.14: 15 residues within 4Å:- Chain E: G.15, S.16, G.17, M.18, K.20, G.158, D.159, K.215, E.216, G.305, T.306, M.308, Y.309, K.339
- Ligands: MG.15
14 PLIP interactions:14 interactions with chain E- Hydrogen bonds: E:S.16, E:G.17, E:M.18, E:M.18, E:D.159, E:D.159, E:K.215, E:E.216, E:E.216, E:G.305
- Salt bridges: E:K.20, E:K.20, E:K.339
- pi-Stacking: E:Y.309
ADP.17: 15 residues within 4Å:- Chain F: G.15, S.16, G.17, M.18, K.20, G.158, D.159, K.215, E.216, G.305, T.306, M.308, Y.309, K.339
- Ligands: MG.18
14 PLIP interactions:14 interactions with chain F- Hydrogen bonds: F:S.16, F:G.17, F:M.18, F:M.18, F:D.159, F:D.159, F:K.215, F:E.216, F:E.216, F:G.305
- Salt bridges: F:K.20, F:K.20, F:K.339
- pi-Stacking: F:Y.309
- 6 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 2 residues within 4Å:- Chain A: Q.139
- Ligands: ADP.2
No protein-ligand interaction detected (PLIP)MG.6: 2 residues within 4Å:- Chain B: Q.139
- Ligands: ADP.5
No protein-ligand interaction detected (PLIP)MG.9: 2 residues within 4Å:- Chain C: Q.139
- Ligands: ADP.8
No protein-ligand interaction detected (PLIP)MG.12: 2 residues within 4Å:- Chain D: Q.139
- Ligands: ADP.11
No protein-ligand interaction detected (PLIP)MG.15: 2 residues within 4Å:- Chain E: Q.139
- Ligands: ADP.14
No protein-ligand interaction detected (PLIP)MG.18: 2 residues within 4Å:- Chain F: Q.139
- Ligands: ADP.17
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lopez, A.J. et al., Structure and function of Plasmodium actin II in the parasite mosquito stages. Plos Pathog. (2023)
- Release Date
- 2023-03-01
- Peptides
- Actin-2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 6 x 9UE: Jasplakinolide(Non-covalent)
- 6 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 6 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lopez, A.J. et al., Structure and function of Plasmodium actin II in the parasite mosquito stages. Plos Pathog. (2023)
- Release Date
- 2023-03-01
- Peptides
- Actin-2: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F